Share Cancellation
DAI summary · Not investment advice
Dongkoo Bio & Pharma will cancel 822,134 treasury common shares, worth KRW 3.0 billion, on November 10, 2026.
Cancellation amount
KRW 3.0 billion
Based on the book value of the shares to be cancelled as of the disclosure date
Key facts
- Acquisition method
- Treasury shares already acquired
- Cancellation date
- Nov 10, 2026May change following consultation with relevant authorities
Commentary
AI commentary · Not investment advice
What happened
Dong-Koo Bio & Pharma decided to cancel 822,134 common shares that it already holds as treasury stock. The planned amount is KRW 3.0 billion, and the cancellation is scheduled for November 10, 2026. The decision was filed on October 28, 2026.
In the company's terms
Relative to the company, the shares to be cancelled compare with 28,464,992 common shares issued in total. The filing states the planned amount equals 3.3% of market capitalization. The shares were not newly acquired for this purpose, since the method is cancellation of previously acquired treasury stock.
What changes for shareholders
For shareholders, the treasury shares are scheduled to be cancelled on November 10, 2026. That is the extent of the dated information in the filing.
Show Korean comments
Comments
No comments yet
Comments from shareholders will appear here.
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist